-
Product Name
Calcium Sensing Receptor antibody
- Documents
-
Description
Calcium Sensing Receptor Rabbit Polyclonal antibody. Positive IF detected in Hela cells. Positive WB detected in HL-60 cells, Jurkat cells. Observed molecular weight by Western-blot: 60-65 kDa
-
Tested applications
ELISA, WB, IF
-
Species reactivity
Human,Mouse,Rat; other species not tested.
-
Alternative names
Calcium Sensing Receptor antibody; CAR antibody; CASR antibody; FHH antibody; FIH antibody; GPRC2A antibody; HHC antibody; HHC1 antibody; NSHPT antibody; PCAR1 antibody
-
Isotype
Rabbit IgG
-
Preparation
This antibody was obtained by immunization of Peptide (Accession Number: NM_000388). Purification method: Antigen affinity purified.
-
Clonality
Polyclonal
-
Formulation
PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
-
Storage instructions
Store at -20℃. DO NOT ALIQUOT
-
Applications
Recommended Dilution:
WB: 1:500-1:5000
IF: 1:10-1:100
-
Validations
HL-60 cells were subjected to SDS PAGE followed by western blot with Catalog No:108816(CASR antibody) at dilution of 1:400
Immunofluorescent analysis of Hela cells, using CASR antibody Catalog No:108816 at 1:25 dilution and Rhodamine-labeled goat anti-rabbit IgG (red).
-
Background
CASR, also named as GPRC2A, PCAR1, belongs to the G-protein coupled receptor 3 family. Changes in extracellular calcium are thought to modulate a balance between proliferation and differentiation in a variety of cell types. The activity of CASR is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. It has been shown to play a major role in regulating parathyroid hormone secretion and subsequently influencing the calcium concentration of extracellular fluids. In normal primary keratinocytes and breast epithelial cells, proliferation is inhibited and elevated extracellular calcium levels trigger differentiation. Malignant transformations of these cell types are accompanied by a loss of responsiveness to the anti-proliferative effects of elevated extracellular calcium. Several disorders of calcium homeostasis have been linked to mutations in the CaSR. These include familial hypocalciuric hypercalcemia (FHH), neonatal severe hyperparathyroidism (NSHPT), and autosomal dominant hypocalemia (ADHypo). The 60-65 kDa band detected by this antibody might represent a degradation product of CASR (PMID: 15718278).
Related Products / Services
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"